Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: A longitudinal study (original) (raw)
Alkyl-Quinolones derivatives as potential biomarkers for Pseudomonas aeruginosa infection chronicity in Cystic Fibrosis
Carine Commun
Scientific Reports, 2021
View PDFchevron_right
2-Aminoacetophenone as a potential breath biomarker for Pseudomonas aeruginosa in the cystic fibrosis lung
R. Laing
2010
View PDFchevron_right
Pseudomonas aeruginosa quorum sensing molecules correlate with clinical status in cystic fibrosis
Andrew Clayton
The European respiratory journal, 2015
View PDFchevron_right
Comparison of culture and qPCR for the detection of Pseudomonas aeruginosa in not chronically infected cystic fibrosis patients
Mario Vaneechoutte, F. Haerynck, MD, PhD
BMC Microbiology, 2010
View PDFchevron_right
Evaluation of specific immune response in early P. aeruginosa infection in cystic fibrosis patients
ersilia fiscarelli
Journal of Cystic Fibrosis, 2014
View PDFchevron_right
Evaluation of quantitative PCR for early diagnosis of Pseudomonas aeruginosa infection in cystic fibrosis: a prospective cohort study
sylvain rosec
Clinical Microbiology and Infection, 2017
View PDFchevron_right
Molecular analysis of changes in Pseudomonas aeruginosa load during treatment of a pulmonary exacerbation in cystic fibrosis
Louise Roddam
Journal of Cystic Fibrosis, 2013
View PDFchevron_right
Infection With Transmissible Strains of Pseudomonas aeruginosa and Clinical Outcomes in Adults With Cystic Fibrosis
Steve Doucette
JAMA, 2010
View PDFchevron_right
Value of serology in predicting Pseudomonas aeruginosa infection in young children with cystic fibrosis
Claire Wainwright
Thorax, 2010
View PDFchevron_right
Quinolones in Community- Acquired Pneumonia; Are They Born Equal
Jamal Wadi Al Ramahi MD, FIDSA
View PDFchevron_right
Assessment of IgG antibodies to Pseudomonas aeruginosa in patients with cystic fibrosis by an enzyme-linked immunosorbent assay (ELISA)
Carlos Levy
Diagnostic Pathology, 2014
View PDFchevron_right
The role of serum Pseudomonas aeruginosa antibodies in the diagnosis and follow-up of cystic fibrosis
Uğur Özçelik
The Turkish journal of pediatrics
View PDFchevron_right
Title: Cyanide in BAL is not diagnostic for P. aeruginosa in children with cystic fibrosis
Barbara Sheil
View PDFchevron_right
PSEUDOMONAS AERUGINOSA INFECTION IN CYSTIC FIBROSIS: Occurrence of Precipitating Antibodies against Pseudomonas Aeruginosa in Relation to the Concentration of Sixteen Serum Proteins and the Clinical and Radiographical Status of thi Lungs
Claudia Mugnaioli
Acta Paediatrica, 1974
View PDFchevron_right
Serum antibodies to Pseudomonas aeruginosa in cystic fibrosis
James Littlewood
Archives of Disease in Childhood, 1986
View PDFchevron_right
PrecipitatingPseudomonas aeruginosa antibodies and antimicrobial therapy in cystic fibrosis patients
Maria Trancassini
European Journal of Clinical Microbiology & Infectious Diseases, 1996
View PDFchevron_right
Multiple antibiotic-resistant Pseudomonas aeruginosa and lung function decline in patients with cystic fibrosis
Michael Konstan
Journal of Cystic Fibrosis, 2012
View PDFchevron_right
Respiratory Infections With Pseudomonas aeruginosa in Children With Cystic Fibrosis
Michael Rock
JAMA, 2002
View PDFchevron_right
Type III apparatus of Pseudomonas aeruginosa as a tool to diagnose pulmonary infection in cystic fibrosis patients
Bianca Neves
APMIS, 2012
View PDFchevron_right
Prediction and diagnosis of early Pseudomonas aeruginosa infection in cystic fibrosis: A follow-up study
James Littlewood
Journal of Clinical Microbiology
View PDFchevron_right
The combination of PCR and serology increases the diagnosis of Pseudomonas aeruginosa colonization/infection in cystic fibrosis
Doroti de Oliveira Garcia
Pediatric Pulmonology, 2007
View PDFchevron_right
Heterogeneity, persistence, and distribution of Pseudomonas aeruginosa genotypes in cystic fibrosis patients
mark Fegan
Journal of clinical …, 1991
View PDFchevron_right
Pseudomonas aeruginosa infection in cystic fibrosis: prevent, eradicate or both?
E. Eber
Thorax, 2010
View PDFchevron_right
Successful implementation of infection control strategies prevents P. aeruginosa transmission among cystic fibrosis patients inside the hospital
Ojan Assadian
GMS hygiene and infection control, 2014
View PDFchevron_right
Comparison of antibiotic susceptibility patterns in Pseudomonas aeruginosa isolated from adult patients with cystic fibrosis (CF) with invasive Pseudomonas aeruginosa from non-CF patients
COLIN GOLDSMITH
Journal of Cystic Fibrosis, 2012
View PDFchevron_right
A critical review of definitions used to describe Pseudomonas aeruginosa microbiological status in patients with cystic fibrosis for application in clinical trials
Pavel Drevinek
Journal of Cystic Fibrosis, 2019
View PDFchevron_right
Proposal of a quantitative PCR-based protocol for an optimal Pseudomonas aeruginosa detection in patients with cystic fibrosis
sylvain rosec
BMC microbiology, 2013
View PDFchevron_right
Comparative Efficacy and Safety of 4 Randomized Regimens to Treat EarlyPseudomonas aeruginosaInfection in Children With Cystic Fibrosis
UMER MUJTABA KHAN
Archives of Pediatrics & Adolescent Medicine, 2011
View PDFchevron_right
The combination of PCR and serology increases the diagnosis ofPseudomonas aeruginosa colonization/infection in cystic fibrosis
Kátia Martins
Pediatric Pulmonology, 2007
View PDFchevron_right